Axxess Pharma to Launch Omega-3 Fish Oil Supplement to US Retail and Online Market by July 1st
20 Maggio 2014 - 2:00PM
Marketwired
Axxess Pharma to Launch Omega-3 Fish Oil Supplement to US Retail
and Online Market by July 1st
Omega-3 Fish Oil to Be Sold Underneath Globally Recognized
TapouT Name
TORONTO, ON--(Marketwired - May 20, 2014) - Axxess Pharma Inc.
(PINKSHEETS: AXXE), a specialty pharmaceutical and nutritional
supplements company, through its wholly owned subsidiary, AllStar
Health Brands Inc., is pleased to announce they will be launching
their latest supplement, Omega-3 fish oil to US retail and online
markets by July 1st. The Omega-3 fish oil will be sold under the
globally recognized TapouT name with all revenues flowing directly
into Axxess Pharma, Inc. Axxess Pharma anticipates generating
significant residual revenues from the $1 billion US Omega-3 oil
market.
Omega-3 fatty acids are some of the most important nutrients to
human health. The number of consumers globally who are aware of
omega-3 fatty acids and their role in health is high, and the
number of people who are specifically consuming omega-3 for health,
has increased dramatically over the past few years.
Dr. Daniel Bagi, President of Axxess Pharma, Inc., stated, "We
are very excited to have finalized the formulation of our newest
TapouT product offering, Omega-3 Fish Oil. Our launch date is
scheduled for July 1st. We have worked closely with Dr. Maese; our
Senior Consultant of Medical Affairs and Private Label
Nutraceuticals to formulate a premium product which could help many
millions of American achieve better health."
Dr. Fred Maese, Senior Consultant of Medical Affairs for Axxess
Pharma, Inc. stated "More than 100 million Americans are at risk
for cardiovascular disease, hypertension, stroke, diabetes,
obesity, elevated triglycerides, mood disorders, osteoarthritis and
premature aging. I strongly recommend a healthy lifestyle and two
daily soft-gel caps of the TapouT Premium Omega-3 Fish Oil,
resulting in better health and optimal quality of life!" Dr. Maese
further stated, "As a cardiologist I endorse this top quality
nutraceutical, especially in those with high blood pressure,
elevated triglycerides and hardening of the arteries. The American
Heart Association and the US Institutes of Health recommend, as
part of a healthy diet, at least 1 gram of omega-3 fatty acids a
day."
About Axxess Pharma Inc.: Axxess Pharma Inc. is a Nevada
Corporation operating through its wholly owned Canadian Subsidiary:
Axxess Pharma Canada Inc., headquartered in Toronto. Axxess is a
specialty Health Care Products Company dedicated to improving
health and quality of life by offering select medicines,
nutritional supplements and over the counter remedies all across
the Americas. Axxess's goal is to bring additional products to the
market and provide new, innovative options for better health
spanning areas such as high cholesterol, blood pressure, acute pain
-- to optimal health management through improved nutritional
supplements. To learn more about our new products TapouT Extreme
Muscle Growth and TapouT Muscle Recovery, please visit:
http://buytapoutme.com and http://www.tapoutmusclerecovery.com.
About TapouT: TapouT is a lifestyle brand that has been at the
forefront of Mixed Martial Arts since its inception in 1997. The
label is rapidly growing into other sports and categories, offering
merchandise for men, women and kids. TapouT has endorsed
high-profile professional athletes who compete in sports such as
basketball, football, baseball, stock car racing, and most
famously, MMA. TapouT is sold in sporting goods stores, specialty
retailers and online. For updates and more information, please
visit TapouT.com.
https://www.facebook.com/TapouT https://twitter.com/TapouT
http://www.youtube.com/tapout
Safe Harbor Statement
Statements about the Company's future expectations and all other
statements in this press release other than historical facts, are
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933, Section 21E of the Securities Exchange
Act of 1934, and as that term is defined in the Private Securities
Litigation Reform Act of 1995. The Company intends that such
forward-looking statements be subject to the safe harbors created
thereby.
The above information contains information relating to the
Company that is based on the beliefs of the Company and/or its
management, as well as assumptions made by any information
currently available to the Company or its management. When used in
this document, the words "anticipate," "estimate," "expect,"
"intend," "plans," "projects," and similar expressions, as they
relate to the Company or its management, are intended to identify
forward-looking statements. Such statements reflect the current
view of the Company regarding future events and are subject to
certain risks, uncertainties and assumptions, including the risks
and uncertainties noted. Should one or more of these risks or
uncertainties materialize, or should underlying assumptions prove
to be incorrect, actual results may vary materially from those
described herein as anticipated, believed, estimated, expected,
intended or projected. In each instance, forward-looking
information should be considered in light of the accompanying
meaningful cautionary statements herein. Factors that could cause
results to differ include, but are not limited to, successful
performance of internal plans, the impact of competitive services
and pricing and general economic risks and uncertainties.
Contact: Investor Relations Taylor Capitol, Inc. Stephen Taylor
(973) 351-3868 staylor@TheStockAlerts.com www.TheStockAlerts.com
Media Relations: Jamie Schnee- PR Nutritional Products
International (561) 544-0719
Grafico Azioni Allstar Health Brands (PK) (USOTC:ALST)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni Allstar Health Brands (PK) (USOTC:ALST)
Storico
Da Dic 2023 a Dic 2024